Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
Holding ACRS?
Track your performance easily

Aclaris Therapeutics (ACRS) Technical Analysis

577 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Aclaris Therapeutics’s (ACRS) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Aclaris Therapeutics is a Sell.
Aclaris Therapeutics’s (ACRS) 20-Day exponential moving average is 1.19, while Aclaris Therapeutics’s (ACRS) share price is $1.17, making it a Sell.
Aclaris Therapeutics’s (ACRS) 50-Day exponential moving average is 1.21, while Aclaris Therapeutics’s (ACRS) share price is $1.17, making it a Sell.

Aclaris Therapeutics (ACRS) Pivot Points

Sep 13, 2024, 07:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.15
1.16
1.17
1.18
1.19
1.20
1.21
Fibonacci
1.16
1.17
1.17
1.18
1.19
1.19
1.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aclaris Therapeutics (ACRS) Moving Averages

Sep 13, 2024, 07:43 AM
Period
Simple
Exponential
MA5
1.17Sell
1.17Sell
MA10
1.17Sell
1.18Sell
MA20
1.20Sell
1.19Sell
MA50
1.24Sell
1.21Sell
MA100
1.20Sell
1.30Sell
MA200
1.17Sell
1.75Sell
Aclaris Therapeutics’s (ACRS) 10-Day exponential moving average is 1.18, while Aclaris Therapeutics’s (ACRS) share price is $1.17, making it a Sell.
Aclaris Therapeutics’s (ACRS) 100-Day exponential moving average is 1.30, while Aclaris Therapeutics’s (ACRS) share price is $1.17, making it a Sell.
Aclaris Therapeutics’s (ACRS) stock price is $1.17 and Aclaris Therapeutics’s (ACRS) 50-day simple moving average is 1.24, creating a Sell signal.
Aclaris Therapeutics’s (ACRS) stock price is $1.17 and Aclaris Therapeutics’s (ACRS) 100-day simple moving average is 1.20, creating a Sell signal.
Aclaris Therapeutics’s (ACRS) stock price is $1.17 and Aclaris Therapeutics’s (ACRS) 200-day simple moving average is 1.17, creating a Sell signal.

Aclaris Therapeutics (ACRS) Technical Indicators

Sep 13, 2024, 07:43 AM
Name
Value
Implied Action
RSI (14)
44.65
Neutral
STOCH (9,6)
39.90
Neutral
STOCHRSI (14)
22.55
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
11.27
Buy
Williams %R
-75.00
Buy
CCI (14)
-40.89
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
40.67
Neutral
ROC
-2.50
Sell
Aclaris Therapeutics’s (ACRS) Relative Strength Index (RSI) is 44.65, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Trend Strength Indicator (ADX) is 11.27, creating a Buy signal.
Aclaris Therapeutics’s (ACRS) Commodity Channel Index (CCI) is -40.89, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Price Rate of Change (ROC) is -2.50, creating a Sell signal.

FAQ

Is ACRS a Buy, Hold, or Sell?
Based on ACRS’s technical indicators, ACRS is a Strong Sell.
    What is ACRS’s RSI (14)?
    ACRS’s RSI (14) is 44.65, which suggests ACRS is a Neutral.
      What is ACRS’s MACD?
      ACRS’s MACD is -0.02, which suggests ACRS is a Sell.
        What is ACRS’s 5-day moving average?
        ACRS’s 5-day moving average is 1.17, which suggests ACRS is a Sell.
          What is ACRS’s 20-day moving average?
          ACRS 20-day moving average is 1.20, which suggests ACRS is a Sell.
            What is ACRS’s 50-day moving average?
            ACRS’s 50-day moving average is 1.24, which suggests ACRS is a Sell.
              What is ACRS’s 200-day moving average?
              ACRS’s 200-day moving average is 1.17, which suggests ACRS is a Sell.
                What is ACRS’s Williams % R (14)?
                ACRS’s Williams % R (14) is -75.00, which suggests ACRS is a Buy.
                  What is ACRS’s CCI (14)?
                  ACRS’s CCI (14) is -40.89, which suggests ACRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis